We use cookies to better understand how you use our site and to improve your experience by personalizing content. Please review our updated Privacy Policy and Terms of Use. If you accept the use of cookies, please click the "I accept" button.I acceptI declineX
Skip navigational links

Life Sciences Newsletter, March 2010


Volume 4, Issue 1
Editor: Karen Gibbs, Esquire

  • U.S. Government Cracks Down on Pharmaceutical and Medical Device Companies and Research Institutions for Export Control and FCPA Violations
    Doreen Edelman, Esquire
    Abbey Baker
  • Toward a Global Biosimilar Strategy: Latest Developments in U.S. and European Regulation
    Keith Harrison, Esquire
  • Indecent Pricing Exposure: State Healthcare Laws Mandating Publication of Price Discounts Could Harm Consumers
    Jim Rill, Esquire
    Mike Cowie, Esquire
  • Seeking Counsel: No Fault? Not Quite
    Arnie Friede, Esquire
  • Brave New FDA: When an Unstoppable Force Meets a (Not) Immovable Object
    Melissa Gilmore, Esquire
© 2018 American Health Lawyers Association. All rights reserved. 1620 Eye Street NW, 6th Floor, Washington, DC 20006-4010 P. 202-833-1100 F. 202-833-1105